Biofrontera Inc
NASDAQ:BFRI
Biofrontera Inc
NASDAQ:BFRI
Price:
0.96
USD
-2.04%
Market Cap:
$11.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Biofrontera Inc
NASDAQ:BFRI
|
US |
|
G
|
Gain Plus Holdings Ltd
HKEX:9900
|
HK |
|
Petroleo Brasileiro SA Petrobras
BOVESPA:PETR4
|
BR |
|
KDX Realty Investment Corp
OTC:KDXRF
|
JP |
|
Shree Digvijay Cement Co Ltd
NSE:SHREDIGCEM
|
IN |
|
PVH Corp
NYSE:PVH
|
US |
|
M
|
Mettler-Toledo International Inc
F:MTO
|
US |
|
Broedrene A & O Johansen A/S
CSE:AOJ B
|
DK |
|
ADMA Biologics Inc
NASDAQ:ADMA
|
US |
|
Azure Minerals Ltd
ASX:AZS
|
AU |
|
R
|
Reservoir Link Energy Bhd
KLSE:RL
|
MY |
|
B L Kashyap and Sons Ltd
NSE:BLKASHYAP
|
IN |
|
T
|
Thinkific Labs Inc
TSX:THNC
|
CA |
|
WLM Participacoes e Comercio de Maquinas e Veiculos SA
BOVESPA:WLMM4
|
BR |
|
I
|
Ihlas Haber Ajansi AS
IST:IHAAS.E
|
TR |
|
Alset Capital Inc
XTSX:GPUS
|
CA |
|
Aker Carbon Capture ASA
OSE:ACC
|
NO |
|
B
|
Beijing Huaru Technology Co Ltd
SZSE:301302
|
CN |
|
A
|
Alphabet Inc
NASDAQ:GOOG
|
US |
|
Grupo Financiero Banorte SAB de CV
OTC:GBOOY
|
MX |
|
Syngene International Ltd
NSE:SYNGENE
|
IN |
|
Z
|
ZAZZ Energy of Sweden AB (publ)
STO:ZAZZ B
|
SE |
|
Xeros Technology Group PLC
LSE:XSG
|
UK |
|
Shenzhen Sunway Communication Co Ltd
SZSE:300136
|
CN |
Income Statement
Earnings Waterfall
Biofrontera Inc
Biofrontera Inc
Income Statement
Biofrontera Inc
Biofrontera Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Interest Expense |
3
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
|
| Revenue |
19
N/A
|
19
+1%
|
22
+18%
|
24
+5%
|
24
+3%
|
29
+21%
|
28
-5%
|
28
0%
|
29
+4%
|
28
-4%
|
29
+5%
|
34
+16%
|
34
+1%
|
33
-2%
|
35
+6%
|
35
+0%
|
37
+6%
|
38
+2%
|
39
+3%
|
37
-5%
|
42
+12%
|
|
| Gross Profit | ||||||||||||||||||||||
| Cost of Revenue |
(9)
|
(9)
|
(11)
|
(12)
|
(13)
|
(15)
|
(15)
|
(15)
|
(15)
|
(15)
|
(15)
|
(17)
|
(17)
|
(17)
|
(18)
|
(19)
|
(19)
|
(18)
|
(16)
|
(13)
|
(11)
|
|
| Gross Profit |
10
N/A
|
10
-1%
|
11
+16%
|
11
-2%
|
11
+2%
|
14
+21%
|
13
-6%
|
13
+0%
|
13
+4%
|
13
-3%
|
14
+8%
|
16
+16%
|
17
+2%
|
16
-2%
|
17
+3%
|
17
-1%
|
19
+12%
|
20
+8%
|
23
+14%
|
24
+3%
|
31
+28%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(18)
|
(18)
|
(20)
|
(34)
|
(25)
|
(38)
|
(40)
|
(28)
|
(31)
|
(33)
|
(36)
|
(39)
|
(38)
|
(39)
|
(36)
|
(36)
|
(36)
|
(37)
|
(39)
|
(42)
|
(42)
|
|
| Selling, General & Administrative |
(18)
|
(17)
|
(19)
|
(32)
|
(26)
|
(40)
|
(44)
|
(35)
|
(35)
|
(37)
|
(38)
|
(39)
|
(38)
|
(38)
|
(35)
|
(35)
|
(34)
|
(33)
|
(36)
|
(38)
|
(38)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(4)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(0)
|
(1)
|
(1)
|
(2)
|
1
|
2
|
4
|
7
|
4
|
4
|
2
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Operating Income |
(8)
N/A
|
(8)
+3%
|
(9)
-7%
|
(23)
-156%
|
(13)
+42%
|
(24)
-84%
|
(27)
-11%
|
(15)
+45%
|
(18)
-20%
|
(20)
-12%
|
(22)
-12%
|
(23)
-4%
|
(21)
+8%
|
(22)
-5%
|
(19)
+16%
|
(19)
-2%
|
(17)
+11%
|
(16)
+5%
|
(16)
0%
|
(18)
-8%
|
(11)
+36%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
(3)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
2
|
(1)
|
(3)
|
(5)
|
(8)
|
(6)
|
(5)
|
(3)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
(1)
|
(1)
|
(1)
|
(1)
|
(12)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
6
|
7
|
7
|
7
|
(0)
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
2
|
1
|
1
|
1
|
(12)
|
(3)
|
2
|
3
|
16
|
9
|
4
|
3
|
3
|
(1)
|
4
|
2
|
2
|
6
|
(0)
|
0
|
1
|
|
| Pre-Tax Income |
(11)
N/A
|
(10)
+5%
|
(10)
+1%
|
(23)
-128%
|
(38)
-61%
|
(29)
+24%
|
(26)
+10%
|
(12)
+52%
|
(1)
+95%
|
(14)
-2 141%
|
(23)
-66%
|
(26)
-17%
|
(20)
+24%
|
(23)
-15%
|
(13)
+42%
|
(13)
+5%
|
(18)
-38%
|
(12)
+35%
|
(17)
-44%
|
(18)
-6%
|
(11)
+40%
|
|
| Net Income | ||||||||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(11)
|
(10)
|
(10)
|
(23)
|
(38)
|
(29)
|
(26)
|
(12)
|
(1)
|
(14)
|
(23)
|
(26)
|
(20)
|
(23)
|
(14)
|
(13)
|
(18)
|
(12)
|
(17)
|
(18)
|
(11)
|
|
| Net Income (Common) |
(11)
N/A
|
(10)
+5%
|
(10)
+0%
|
(23)
-126%
|
(38)
-61%
|
(29)
+24%
|
(26)
+10%
|
(12)
+52%
|
(1)
+95%
|
(14)
-2 039%
|
(23)
-66%
|
(26)
-17%
|
(20)
+24%
|
(23)
-15%
|
(14)
+42%
|
(13)
+5%
|
(18)
-38%
|
(12)
+35%
|
(17)
-44%
|
(18)
-6%
|
(11)
+40%
|
|
| EPS (Diluted) |
-27.47
N/A
|
-26.05
+5%
|
-25.92
+0%
|
-58.49
-126%
|
-85.7
-47%
|
-33.27
+61%
|
-27.45
+17%
|
-10.85
+60%
|
-0.61
+94%
|
-10.29
-1 587%
|
-16.67
-62%
|
-19.3
-16%
|
-13.02
+33%
|
-6.37
+51%
|
-2.65
+58%
|
-2.22
+16%
|
-3.22
-45%
|
-1.29
+60%
|
-1.77
-37%
|
-1.63
+8%
|
-1.04
+36%
|
|
Switch to:
Switch to:
See Also
Discover More
